Tasos Konidaris
Executive Vice President & CFO · 2 filings · Latest: Mar 3, 2026
Amneal Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMRX | Tasos Konidaris | Executive Vice President & CFO | Mar 4, 2026 | Option Exercise | — | 43,982 | — | 471,469 | |
AMRX | Tasos Konidaris | Executive Vice President & CFO | Mar 3, 2026 | Option Exercise | — | 589,883 | — | 657,304 | |
AMRX | Konidaris Tasos | — | Aug 15, 2025 | Proposed Sale | $9.39 | 219,159 | $2.1M | — | |
AMRX | Konidaris Tasos | — | Aug 13, 2025 | Proposed Sale | $9.27 | 169,206 | $1.6M | — | |
AMRX | Konidaris Tasos | — | Aug 13, 2025 | Proposed Sale | $9.02 | 111,635 | $1.0M | — | |
AMRX | Konidaris Tasos | — | Mar 5, 2025 | Proposed Sale | $8.84 | 100,000 | $884.0K | — |